Skip to content
Acting Auditions – Lifestyle
Author:
BioNexus Gene Lab Corp.
Hugel brings WELLAGE to Sephora US with OLIVE YOUNG, strengthening global skincare growth
August 20, 2026
Hugel reports record first-half earnings driven by strong botulinum toxin growth
August 6, 2026
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
July 28, 2026
Hugel Aesthetics Expands U.S. Presence with Commercial, Medical and Scientific Investments
July 22, 2026
Hugel showcases global K-aesthetics momentum at AMWC KOREA
June 22, 2026
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
May 29, 2026
Hugel highlights global vision for K-aesthetics
May 22, 2026
Hugel reports record Q1 earnings, driving strong global growth in aesthetics
May 8, 2026
Hugel to enter ECM-based injectable market with aesthetic portfolio expansion
April 1, 2026
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
March 11, 2026